Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Innocan Pharma Corp.

Start price
Target price
Perf. (%)
€0.26
18.09.23
€1.00
18.09.24
-37.77%
02:15

Differentiated customer and product portfolio
Leading role in innovation
Revenue growth > 30% per year expected
Higher risks for its business
buy
Cedergrenska Ab

Start price
Target price
Perf. (%)
€1.02
18.09.23
€1.40
18.09.24
119.61%
02:15

buy
Integrum Ab

Start price
Target price
Perf. (%)
€1.94
18.09.23
€4.00
18.09.24
27.84%
02:15

Nucana Plc

Start price
Target price
Perf. (%)
€6.60
16.09.24
-
16.09.25
-53.33%
18.09.24

Risky Investment
buy
Turk Hava Yollari A.s.

Start price
Target price
Perf. (%)
€74.00
04.09.24
€75.00
04.09.25
-0.68%
18.09.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Turk Telekomunikasyon As

Start price
Target price
Perf. (%)
€2.20
05.09.24
€2.00
05.09.25
-3.64%
18.09.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€0.92
15.09.24
€1.00
15.09.25
-6.17%
18.09.24

Fair valuation
Small cyclical dependencies
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Technip Energies N.v.

Start price
Target price
Perf. (%)
€22.62
18.09.24
€45.00
-
18.09.24

Could be very worthwhile Investment >20% year
buy
4sc AG

Start price
Target price
Perf. (%)
€8.75
20.03.24
-
20.03.25
-25.71%
17.09.24

Nucana Plc

Start price
Target price
Perf. (%)
€4.56
16.09.24
-
16.09.25
-24.12%
17.09.24

Intel Corp.

Start price
Target price
Perf. (%)
€7.25
05.09.24
€9.00
05.09.25
18.62%
17.09.24

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
positive Cash Flow expected
Nucana Plc

Start price
Target price
Perf. (%)
€6.60
16.09.24
-
16.09.25
-34.55%
17.09.24

Good culture
Risky Investment
No Innovation
buy
Terns Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€7.20
09.09.24
-
09.09.25
23.61%
17.09.24

buy
Selectquote Inc.

Start price
Target price
Perf. (%)
€2.12
13.09.24
-
13.09.25
-23.11%
17.09.24

Xortx Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.74
03.09.24
-
03.09.25
-7.76%
17.09.24

Probably not worthwhile Investment
Terns Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.10
09.09.24
-
09.09.25
9.88%
17.09.24

buy
Phunware Inc.

Start price
Target price
Perf. (%)
€3.32
09.09.24
-
09.09.25
-8.73%
17.09.24

Janone Inc.

Start price
Target price
Perf. (%)
€2.26
16.08.24
-
16.09.24
-20.35%
17.09.24

Novo-nordisk As

Start price
Target price
Perf. (%)
€123.68
16.08.24
-
16.09.24
-0.49%
17.09.24

Nikola Corp.

Start price
Target price
Perf. (%)
€0.32
16.08.24
-
16.09.24
-
17.09.24

Hensoldt AG

Start price
Target price
Perf. (%)
€36.08
16.08.24
-
16.09.24
-15.24%
17.09.24

Innocan Pharma Corp.

Start price
Target price
Perf. (%)
€0.16
16.08.24
-
16.09.24
-0.31%
17.09.24

Alerion Clean Power

Start price
Target price
Perf. (%)
€15.58
16.08.24
-
16.09.24
5.52%
17.09.24

buy
Arm Holdings Plc

Start price
Target price
Perf. (%)
€57.18
16.09.23
-
16.09.24
119.66%
17.09.24

Xortx Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.31
03.09.24
-
03.09.25
-28.36%
16.09.24